By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Oxxon Therapeutics Inc. 

2nd Floor Florey House
3 Robert Robinson Avenue

Oxford Science Park
Oxford    OX4 4GP  United Kingdom
Phone: 44-0-1865-398100 Fax: 44-0-1865-398101



Company News
Oxxon Therapeutics Inc. Chairman and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell 1/21/2010 8:57:01 AM
Oxxon Therapeutics Inc. to be Acquired by Oxford BioMedica PLC (OXB.L) for GBP 16 Million 3/12/2007 8:36:12 AM
Oxxon Therapeutics Inc.' Hi-8(TM) MEL Therapeutic Vaccine Demonstrates Potential For Treatment Of Advanced Metastatic Melanoma 6/6/2006 11:27:21 AM
Oxxon Therapeutics Inc. To Present Phase IIA Survival Data For Its HI-8(TM) Mel Therapeutic Vaccine As A Treatment For Advanced Metastatic Melanoma 5/30/2006 10:22:14 AM
Oxxon Therapeutics Inc. HI-8(TM) HBV Therapeutic Vaccine Proves Safe And Efficacious In Treating Chronic Hepatitis B 4/27/2006 1:18:41 PM
Oxxon Therapeutics Inc. Appoints Craig R. Smith, M.D. Chairman And John Berriman Executive Deputy Chairman Of Its Board Of Directors 4/11/2006 11:16:59 AM
Oxxon Therapeutics Inc. Reports Positive Preliminary Phase IIa Data With Chronic Hepatitis B Therapeutic Vaccine 11/11/2005 10:44:43 AM
Xenova Group PLC (XNVA) Licenses DISC-HSV And DISC-GM-CSF Vector Technologies To Oxxon Therapeutics Inc.; $83 Million; Stock Up10/19/2005 5:12:16 PM
Oxxon Therapeutics Inc. Announces The Promotion Of Dr. Mark Payton To Vice President Of Corporate Development10/19/2005 5:10:58 PM
Oxxon Therapeutics Ltd Launches U.S. Operation And Announces New Name 10/19/2005 5:10:52 PM